Dopaminergic function in a family with the PARK6 form of autosomal recessive Parkinson's syndrome

Journal of Neural Transmission

Volumn 112, Issue 10, 2005, Pages 1345-1353

  Kessler, K R ^a   Hamscho, N ^a   Morales, B ^b   Menzel, C ^a   Barrero, F ^b   Vives, F ^b   Gispert, S ^a   Auburger, G ^a  

^a GOETHE UNIVERSITY   (Germany)

^b HOSPITAL UNIVERSITARIO SAN CECILIO   (Spain)

Author keywords

Dopamine transporter; PARK6; Parkinson's disease; Single photon emission tomography

Indexed keywords

AMIDE; DOPAMINE 2 RECEPTOR; DOPAMINE TRANSPORTER; IODINE 123;

ADULT; ARTICLE; AUTOSOMAL RECESSIVE DISORDER; BINDING AFFINITY; CLINICAL ARTICLE; CLINICAL FEATURE; COMPARATIVE STUDY; CORPUS STRIATUM; DOPAMINERGIC ACTIVITY; FEMALE; GENE MUTATION; HUMAN; MALE; PARKINSON DISEASE; POSTSYNAPTIC POTENTIAL; PRESYNAPTIC NERVE; PRIORITY JOURNAL; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY;

ADULT; BENZAMIDES; CARBON RADIOISOTOPES; CORPUS STRIATUM; DOPAMINE; DOPAMINE ANTAGONISTS; DOPAMINE PLASMA MEMBRANE TRANSPORT PROTEINS; FAMILY HEALTH; FEMALE; GENES, RECESSIVE; HUMANS; IODINE RADIOISOTOPES; MALE; MIDDLE AGED; PARKINSON DISEASE; PROTEIN KINASES; PYRROLIDINES; SIBLINGS; SUBSTANTIA NIGRA; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON; TROPANES;

EID: 25144433763     PISSN: 03009564     EISSN: 14351463     Source Type: Journal    
DOI: 10.1007/s00702-005-0281-9     Document Type: Article

References (26)

1. A Antonini J Schwarz WH Oertel O Pogarell KL Leenders 1997 Long-term changes of striatal dopamine D2 receptors in patients with Parkinson's disease: a study with positron emission tomography and [11C]raclopride. Mov Disord 12 33 38
2. MF Beal 2003 Mitochondria, oxidative damage, and inflammation in Parkinson's disease. Ann NY Acad Sci 991 120 131
3. 123I]-FP-CIT study group. Mov Disord 13 503 510
4. R Benecke P Strumper H Weiss 1993 Electron transfer complexes I and IV of platelets are abnormal in Parkinson's disease but normal in Parkinson-plus syndromes. Brain 116 1451 1463
5. AR Bentivoglio P Cortelli EM Valente T Ialongo A Ferraris A Elia P Montagna A Albanese 2001 Phenotypic characterisation of autosomal recessive PARK6-linked parkinsonism in three unrelated Italian families. Mov Disord 16 999 1006
6. H Bernheimer W Birkmayer O Hornykiewicz K Jellinger F Seitelberger 1973 Brain dopamine and the syndromes of Parkinson and Huntington. Clinical, morphological and neurochemical correlations. J Neurol Sci 20 415 455
7. KA Cheon YH Ryu YK Kim K Namkoong CH Kim JD Lee 2003 Dopamine transporter density in the basal ganglia assessed with [123I]IPT SPET in children with attention deficit hyperactivity disorder. Eur J Nucl Med Mol Imaging 30 306 311
8. KA Cheon YH Ryu K Namkoong CH Kim JJ Kim JD Lee 2004 Dopamine transporter density of the basal ganglia assessed with [123I]IPT SPECT in drug-naive children with Tourette's disorder. Psychiatry Res 130 85 95
9. Fahn S, Elton RL (1987) Unified Parkinson's Disease rating scale. In: Fahn S et al. (eds) Recent development in Parkinson's disease II. McMillan Healthcare Information, Florham Park (NJ), pp 153-163
10. P Foley P Riederer 2000 Influence of neurotoxins and oxidative stress on the onset and progression of Parkinon's disease. J Neurol 247 82 94
11. RR Gainetdinov MG Caron 2003 Monoamine transporters: from genes to behavior. Ann Rev Pharmacol Toxicol 43 261 284
12. R Hilker C Klein M Ghaemi B Kis T Strotmann LJ Ozelius O Lenz P Vieregge K Herholz WD Heiss PP Pramstaller 2001 Positron emission tomographic analysis of the nigrostriatal dopaminergic system in familial parkinsonism associated with mutations in the parkin gene. Ann Neurol 49 367 376
13. P Jenner CW Olanow 1996 Oxidative stress and the pathogenesis of Parkinson's disease. Neurology 47 161 170
14. V Kaasinen HM Ruottinen K Nagren P Lehikoinen V Oikonen JO Rinne 2000 Upregulation of putaminal dopamine D2 receptors in early Parkinson's disease: a comparative PET study with [11C] raclopride and [11C]N-methylspiperone. J Nucl Med 41 65 70
15. NL Khan EM Valente AR Bentivoglio NW Wood A Albanese DJ Brooks P Piccini 2002 Clinical and subclinical dopaminergic dysfunction in PARK6-linked parkinsonism: an 18F-dopa PET study. Ann Neurol 52 849 853
16. J Lavalaye J Booij L Reneman JBA Habraken EA van Royen 2000 Effect of age and gender on dopamine transporter imaging with 123I-FP-CIT SPET in healthy volunteers. Eur J Nucl Med Mol Imaging 27 867 869
17. SA Oliveira WK Scott ER Martin MA Nance RL Watts JP Hubble WC Koller R Pahwa MB Stern BC Hiner WG Ondo FHJ Allen BL Scott CG Goetz GW Small F Mastaglia JM Stajich F Zhang MW Booze MP Winn LT Middleton JL Haines MA Pericak-Vance JM Vance 2003 Parkin mutations and susceptibility alleles in late-onset Parkinson's disease. Ann Neurol 53 624 629
18. P Piccini PK Morrish N Turjanski GV Sawle DJ Burn RA Weeks MH Mark D Maraganore AJ Lees DJ Brooks 1997 Dopaminergic functions in familial Parkinson's disease: a clinical and 18F-DOPA positron emission tomography study. Ann Neurol 41 222 229
19. Plotkin M, Amthauer H, Klaffke S, Kühn A, Lüdemann L, Arnold G, Wernecke K-D, Kupsch A, Felix R, Venz S (2004) Combined 123I-FP-CIT and 123I-IBZM SPECT for the diagnosis of parkinsonian syndromes: study on 72 patients. J Neural Transm (DOI 10.1007/200702-004-0208-x; epub ahead of print)
20. A Samii K Markopoulou ZK Wszolek V Sossi T Dobko E Mak DB Calne AJ Stoessl 1999 PET studies of parkinsonism associated with mutation in the alpha-synuclein gene. Neurology 53 2097 2102
21. J Schwarz K Tatsch G Arnold M Ott C Trenkwalder CM Kirsch WH Oertel 1993 123I-iodobenzamide-SPECT in 83 patients with de novo parkinsonism. Neurology 43 [Suppl 6] S17 S20
22. A Sidhu C Wersinger P Vernier 2004 Alpha-synuclein regulation of the dopaminergic transporter: a possible role in the pathogenesis of Parkinson's disease. FEBS Lett 565 1 5
23. H Sjoholm T Bratlid J Sundsfjord 2004 123I-beta-CIT SPECT demonstrates increased presynaptic dopamine transporter binding sites in basal ganglia in vivo in schizophrenia. Psychopharmacology (Berl) 173 27 31
24. EM Valente AR Bentivoglio PH Dixon A Ferraris T Ialongo M Frontali A Albanese NW Wood 2001 Localization of a novel locus for autosomal recessive early-onset parkinsonism, PARK6, on human chromosome 1p35-p36. Am J Hum Genet 68 895 900
25. EM Valente PM Abou-Sleiman V Caputo MMK Muqit K Harvey S Gispert Z Ali D Del Turco AR Bentivoglio DG Healy A Albanese R Nussbaum R Gonzalez-Maldonado T Deller S Salvi P Cortelli WP Gilks DS Latchman RJ Harvey B Dallapiccola G Auburger NW Wood 2004 Hereditary early-onset Parkinson's disease caused by mutations in PINK1. Science 304 1158 1160
26. EM Valente F Brancati A Ferraris EA Graham MB Davis MM Breteler T Gasser V Bonifati AR Bentivoglio G De Michele A Durr P Cortelli D Wassilowsky BS Harhangi N Rawal V Caputo A Filla G Meco BA Oostra A Brice A Albanese B Dallapiccola NW Wood 2002 PARK6-linked parkinsonism occurs in several European families. Ann Neurol 51 14 18